Clinical impact of absolute SPECT/CT quantification in theranostics and dosimetry
By Partha Ghosh, MD, Siemens Healthineers | 24-06-2020
Data courtesy of CHRU de Brest, Brest, France.
Integration of SPECT/CT imaging and radionuclide therapy for an ever-increasing spectrum of cancers points to a promising future for such therapies. Explore this white paper and discover how accurate quantification of tracer concentration with SPECT/CT is potentially key to dosimetry and optimal therapy outcomes.